Mirtazapine in Alzheimer-associated Weight Loss

CHU Brugmann University Hospital

Status: Completed

Conditions: Mixed Dementia; Weight Loss; Alzheimer's Disease; Dementia

Treatments: Drug: mirtazapine

Study type: Observational

Funder types: Other

Identifiers

NCT01505504

MIRTA-2012

Details and patient eligibility

About

Weight loss is a frequent problem associated with Alzheimers disease (AD). Mirtazapine has weight loss as a frequent side effect.

The aim of this retrospective study is to check whether mirtazapine 30 mg (once daily) can counteract weight loss in patients with AD or mixed dementia (AD + vascular).

Enrollment: 22 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• AD or mixed dementia
• documented weight loss
• mirtazapine 30 mg explicitly prescribed against weight loss

Exclusion criteria

• no treatment compliance
• other causes of weight loss
• other interventions against weight loss